FDMT

NASDAQ 已收盘

4D Molecular Therapeutics

10.72 USD
▲+0.26+2.49%
盘后 10.50 -2.05%
2026-11-19
市值
$576.76M
市盈率
—
EPS
-2.92
股息率
—
52 周区间
6.96 – 16.93
成交量
758.73K
Beta
2.91
目标价
28.09
52W 低 6.9652W 高 16.93
价格走势

公司简介

4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States. The company’s lead product candidate is 4D-150 for the treatment of retinal vascular diseases by providing multi-year sustained production of anti-VEGF from the retina with intravitreal injection, as well as for treating wet age-related macular degeneration and diabetic macular edema. It is...